Autocrine IL-2-dependent growth of a newly established CD3+, CD16−, CD56+, CD57+, JH−, TCRβ−, TCRγ− leukemia cell line (NOI-90)
- DOI
- 10.1038/sj.leu.2400562
- Published
- 1997-02-01
- Container
- Leukemia
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/sj.leu.2400562,
title = {Autocrine IL-2-dependent growth of a newly established CD3+, CD16−, CD56+, CD57+, JH−, TCRβ−, TCRγ− leukemia cell line (NOI-90)},
author = {Y Sahraoui and M Perraki and M Theodoropoulou and M Allouche and A Tsapis and A Ammar and C Clemenceau and S Bokogiorgou and T Yacci and G Katrinakis and C Jasmin and V Georgoulias},
year = {1997},
journal = {Leukemia},
doi = {10.1038/sj.leu.2400562},
url = {https://doi.org/10.1038/sj.leu.2400562}
}RIS
TY - JOUR TI - Autocrine IL-2-dependent growth of a newly established CD3+, CD16−, CD56+, CD57+, JH−, TCRβ−, TCRγ− leukemia cell line (NOI-90) AU - Y Sahraoui AU - M Perraki AU - M Theodoropoulou AU - M Allouche AU - A Tsapis AU - A Ammar AU - C Clemenceau AU - S Bokogiorgou AU - T Yacci AU - G Katrinakis AU - C Jasmin AU - V Georgoulias PY - 1997 JO - Leukemia DO - 10.1038/sj.leu.2400562 UR - https://doi.org/10.1038/sj.leu.2400562 ER -
APA
Sahraoui, Y., Perraki, M., Theodoropoulou, M., Allouche, M., Tsapis, A., Ammar, A., Clemenceau, C., Bokogiorgou, S., Yacci, T., Katrinakis, G., Jasmin, C., & Georgoulias, V. (1997). Autocrine IL-2-dependent growth of a newly established CD3+, CD16−, CD56+, CD57+, JH−, TCRβ−, TCRγ− leukemia cell line (NOI-90). Leukemia. https://doi.org/10.1038/sj.leu.2400562
Source records
- crossref · retrieved 2026-09-27T09:54:03.784Z